Table 3. Patient characteristics.
| Characteristics | Value |
|---|---|
| Gender, n (%) | |
| Male | 120 (49.0) |
| Female | 125 (51.0) |
| Age (mean; SD) (years) | 61.5 (±13.1) |
| Myasthenia gravis, n (%) | |
| Present | 36 (14.7) |
| Absent | 209 (85.3) |
| WHO classification, n (%) | |
| A | 42 (17.1) |
| AB | 100 (40.8) |
| B1 | 22 (9.0) |
| B2 | 44 (18.0) |
| B3 | 34 (13.9) |
| Complete necrosis | 2 (0.8) |
| Metaplastic | 1 (0.4) |
| Preoperative treatment, n (%) | |
| None | 220 (89.8) |
| Induction chemotherapy | 24 (9.8) |
| Radiotherapy | 1 (0.4) |
| Adjuvant treatment, n (%) | |
| None | 189 (77.2) |
| Chemotherapy | 16 (6.5) |
| Radiotherapy | 40 (16.3) |
WHO, world health organization; SD, standard deviation.